Pinnacle Wealth Planning Services
RCKT icon

Pinnacle Wealth Planning Services’s Rocket Pharmaceuticals RCKT Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451 Sell
132
-2,434
-95% -$8.09K ﹤0.01% 2659
2026
Q1 		$9.19K Hold
2,566
– – ﹤0.01% 2033
2025
Q4 		$9.01K Buy
+2,566
New +$8.78K ﹤0.01% 2052

Other funds holding RCKT

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Pinnacle Wealth Planning Services's RCKT Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its Rocket Pharmaceuticals (RCKT) stake by 95% in Q2 2026, selling an estimated $8.09K and leaving 132 shares worth $451. The position accounts for ﹤0.01% of the portfolio, ranked #2659.

Pinnacle Wealth Planning Services first reported a position in RCKT in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.19K in Q1 2026. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Pinnacle Wealth Planning Services held 132 shares of Rocket Pharmaceuticals worth $451 as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 2,434 Rocket Pharmaceuticals shares in Q2 2026, an estimated $8.09K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2659 holding.
  • Pinnacle Wealth Planning Services first reported a position in Rocket Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Wealth Planning Services's Rocket Pharmaceuticals position peaked at $9.19K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.